Skip to content
10-Q

Quarterly Report

SOPHIRIS BIO INC.

0001437749-19-016175

← back to feed
Filed
Aug 9, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Aug 1, 2019 30.22M sh
Operating Cash Flow Q2 2019 · Jun 30, 2019 −$5.74M
Operating Cash Flow Q2 2019 · Jun 30, 2018 −$7.35M
Long Term Debt Q2 2019 · Jun 30, 2019 $3.76M
Long Term Debt Q2 2019 · Dec 31, 2018 $5.09M
Short Term Debt Q2 2019 · Jun 30, 2019 $2.65M
Short Term Debt Q2 2019 · Dec 31, 2018 $1.92M
Cash And Equivalents Q2 2019 · Jun 30, 2019 $4.97M
Cash And Equivalents Q2 2019 · Dec 31, 2018 $11M
Cash And Equivalents Q2 2019 · Jun 30, 2018 $13.94M
Cash And Equivalents Q2 2019 · Dec 31, 2017 $16.09M
Stockholders Equity Q2 2019 · Jun 30, 2019 −$2.38M
Stockholders Equity Q2 2019 · Mar 31, 2019 −$402K
Stockholders Equity Q2 2019 · Dec 31, 2018 $1.74M
Stockholders Equity Q2 2019 · Jun 30, 2018 −$1.36M
Stockholders Equity Q2 2019 · Mar 31, 2018 $4.55M
Stockholders Equity Q2 2019 · Dec 31, 2017 $7.65M
Current Liabilities Q2 2019 · Jun 30, 2019 $4.48M
Current Liabilities Q2 2019 · Dec 31, 2018 $4.97M
Total Liabilities Q2 2019 · Jun 30, 2019 $8.82M
Total Liabilities Q2 2019 · Dec 31, 2018 $11.46M
Current Assets Q2 2019 · Jun 30, 2019 $6.32M
Current Assets Q2 2019 · Dec 31, 2018 $13.2M
Total Assets Q2 2019 · Jun 30, 2019 $6.44M
Total Assets Q2 2019 · Dec 31, 2018 $13.2M
Sga Expense Q2 2019 · Jun 30, 2019 $1.22M
Sga Expense Q2 2019 · Jun 30, 2019 $2.47M
Sga Expense Q2 2019 · Jun 30, 2018 $1.1M
Sga Expense Q2 2019 · Jun 30, 2018 $2.34M
Rd Expense Q2 2019 · Jun 30, 2019 $1.09M
Rd Expense Q2 2019 · Jun 30, 2019 $2.64M
Rd Expense Q2 2019 · Jun 30, 2018 $3.59M
Rd Expense Q2 2019 · Jun 30, 2018 $6.92M
Net Income Q2 2019 · Jun 30, 2019 −$2.16M
Net Income Q2 2019 · Jun 30, 2019 −$4.52M
Net Income Q2 2019 · Jun 30, 2018 −$6.1M
Net Income Q2 2019 · Jun 30, 2018 −$9.43M
Capex Q2 2019 · Jun 30, 2018 $3K